Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Mycoses 2Leukemia 2Invasive Fungal Infections 2Pulmonary Aspergillosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neoplasms 1Leukemia, Myelomonocytic, Acute 1Invasive Pulmonary Aspergillosis 1Hematologic Neoplasms 1HIV Infections 1Colorectal Neoplasms 1Aspergillosis 1Anastomotic Leak 1

Interventions

Cyclophosphamide 87fludarabine 74Tacrolimus 45fludarabine phosphate 44Mycophenolic Acid 42Whole-Body Irradiation 41Busulfan 35Melphalan 31Antilymphocyte Serum 24thymoglobulin 22Methotrexate 22Rituximab 21venetoclax 20Standard of Care 20Sirolimus 20Azacitidine 20Thiotepa 19Stem Cell Transplantation 18Granulocyte Colony-Stimulating Factor 18Practice Guidelines as Topic 16Cytarabine 16Nivolumab 15Filgrastim 15Dexamethasone 14Cyclosporine 13Bortezomib 13Mesna 12Peripheral Blood Stem Cell Transplantation 11trametinib 10Specimen Handling 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hematologic Neoplasms × Amphotericin B × Clear all
NCT00750737 2016-09-29

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

M.D. Anderson Cancer Center

Phase 3 Completed
46 enrolled 6 charts
Other hematologic neoplasm

Invasive Fungal Infections, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡